This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Synthon B.v.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Juan Cucala Escoi: Innovator in Pharmaceutical Compounds
Introduction
Juan Cucala Escoi is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on venlafaxine besylate. His research and inventions have the potential to improve treatment options for various medical conditions.
Latest Patents
Juan Cucala Escoi holds a patent for venlafaxine besylate. This compound offers certain advantages over venlafaxine hydrochloride and is useful in forming pharmaceutical compositions for treating venlafaxine-treatable diseases and conditions. Venlafaxine besylate can be easily formulated into an extended-release dosage form, including a hydrogel tablet and other matrix-based tablet compositions. A preferred tablet-making process involves hot melt granulation.
Career Highlights
Juan Cucala Escoi is associated with Synthon B.V., where he continues to advance his research in pharmaceutical innovations. His work has garnered attention for its potential impact on drug formulation and delivery.
Collaborations
Some of his coworkers include Rolf Keltjens and Johannes Jan Platteeuw. Their collaboration contributes to the innovative environment at Synthon B.V.
Conclusion
Juan Cucala Escoi is a prominent figure in the pharmaceutical industry, with a focus on developing advanced drug formulations. His work on venlafaxine besylate exemplifies his commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile